Search

Avian pathogenic Escherichia coli (APEC) is a common bacterial pathogen infecting chickens, resulting in economic losses to the poultry industry worldwide. In particular, APEC O1, one of the most common serotypes of APEC, is considered problematic due to its zoonotic potential. Therefore, many attempts have been made to develop an effective vaccine against APEC O1. In fact, the lipopolysaccharide (LPS) O‐antigen of APEC O1 has been shown to be a potent antigen for inducing specific protective immune responses. However, the detailed structure of the O‐antigen of APEC O1 is not clear. The present study demonstrates the first synthesis of a pentasaccharide repeating unit of LPS derived from virulent E. coli O1 and its conjugate with BSA. ELISA tests using the semi‐synthetic glycoconjugate and the APEC O1 immune chicken serum revealed that the pentasaccharide is a glycotope candidate of APEC O1, with great potential as an antigen for vaccine development. [ABSTRACT FROM AUTHOR]

Innenrücktitelbild: Synthesis of a Pentasaccharide Repeating Unit of Lipopolysaccharide Derived from Virulent E. coli O1 and Identification of a Glycotope Candidate of Avian Pathogenic E. coli O1 (Angew. Keywords: avian pathogenic Escherichia coli; boron-mediated aglycon delivery; glycoconjugate; glycotope; -rhamnoside EN avian pathogenic Escherichia coli boron-mediated aglycon delivery glycoconjugate glycotope -rhamnoside 2195 2195 1 01/20/21 20210125 NES 210125 B Die Identifizierung des Glykotops b des aviären pathogenen I E. coli i (APEC) O1 ist wichtig für die Entwicklung einer neuen Generation von verbesserten und sicheren Impfstoffen. Avian pathogenic Escherichia coli, boron-mediated aglycon delivery, glycoconjugate, glycotope, -rhamnoside. [Extracted from the article]